[Prevalence and course of fatigue in breast cancer: the kind of chemotherapy plays a role].
de Jong
Nynke
N
Universiteit Maastricht, Cluster Zorgwetenschappen, Sectie Verplegingswetenschap, Maastricht, NL. N.deJong@ZW.unimaas.nl
Candel
Math
M
Schouten
Harry
H
Abu-Saad
Huda Huijer
HH
Courtens
Annemie
A
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000451:nursing* / Q000523:psychology / Q000601:surgery; D017024:Chemotherapy, Adjuvant / Q000451:nursing; D003430:Cross-Sectional Studies; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005221:Fatigue / Q000139:chemically induced* / Q000453:epidemiology / Q000523:psychology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008408:Mastectomy / Q000451:nursing / Q000523:psychology; D015412:Mastectomy, Segmental / Q000451:nursing / Q000523:psychology; D008875:Middle Aged; D012803:Sick Role